Search Results - "MAGGIO, Sonia C"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions by Rosato, Roberto R, Almenara, Jorge A, Maggio, Sonia C, Coe, Stefanie, Atadja, Peter, Dent, Paul, Grant, Steven

    Published in Molecular cancer therapeutics (01-10-2008)
    “…The role of reactive oxygen species (ROS) production on DNA damage and potentiation of fludarabine lethality by the histone deacetylase inhibitor (HDACI)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions by Rosato, Roberto R, Almenara, Jorge A, Kolla, Sarah S, Maggio, Sonia C, Coe, Stefanie, Giménez, Maria S, Dent, Paul, Grant, Steven

    Published in Molecular cancer therapeutics (01-02-2007)
    “…The mechanism and functional significance of XIAP and Mcl-1 down-regulation in human leukemia cells exposed to the histone deacetylase inhibitor vorinostat and…”
    Get full text
    Journal Article
  4. 4

    Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells by Rosato, Roberto R, Almenara, Jorge A, Maggio, Sonia C, Atadja, Peter, Craig, Ruth, Vrana, Julie, Dent, Paul, Grant, Steven

    Published in Molecular cancer therapeutics (01-11-2005)
    “…Interactions between the novel histone deacetylase inhibitor LAQ824 and the cyclin-dependent kinase inhibitor roscovitine were examined in human leukemia…”
    Get full text
    Journal Article
  5. 5

    The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells by MAGGIO, Sonia C, ROSATO, Roberto R, KRAMER, Lora B, DAI, Yun, RAHMANI, Mohamed, PAIK, David S, CZARNIK, Ann C, PAYNE, Shawn G, SPIEGEL, Sarah, GRANT, Steven

    Published in Cancer research (Chicago, Ill.) (01-04-2004)
    “…Interactions between the novel benzamide histone deacetylase (HDAC) inhibitor MS-275 and fludarabine were examined in lymphoid and myeloid human leukemia cells…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Role of histone deacetylase inhibitor-induced ROS and DNA damage in LAQ-824/fludarabine antileukemic interactions by Rosato, Roberto R., Almenara, Jorge A., Maggio, Sonia C., Coe, Stefanie, Atadja, Peter, Dent, Paul, Grant, Steven

    Published in Molecular cancer therapeutics (01-10-2008)
    “…The role of ROS production on DNA damage and potentiation of fludarabine (F) lethality by the HDAC inhibitor LAQ-824 was investigated in human leukemia cells…”
    Get full text
    Journal Article
  8. 8

    Protein Kinase C-dependent Activation of the Tumor Necrosis Factor Receptor-mediated Extrinsic Cell Death Pathway Underlies Enhanced Apoptosis in Human Myeloid Leukemia Cells Exposed to Bryostatin 1 and Flavopiridol1 by Leanne Cartee, Sonia C. Maggio, Rebecca Smith, Heidi M. Sankala, Paul Dent, Steven Grant

    Published in Molecular cancer therapeutics (01-01-2003)
    “…Interactions between the protein kinase C activator bryostatin 1 and the cyclin-dependent kinase (CDK) inhibitor flavopiridol (FP) have been examined in human…”
    Get full text
    Journal Article